Frequencies for first 10,000 rows of indi_pt variable in indi2008q4 dataset : 'Preferred Term'-level medical | terminology describing the Indication | for use | Freq. Percent Cum. ----------------------------------------+----------------------------------- 21-HYDROXYLASE DEFICIENCY | 2 0.02 0.02 5Q MINUS SYNDROME | 2 0.02 0.04 ABDOMINAL DISCOMFORT | 9 0.09 0.13 ABDOMINAL DISTENSION | 2 0.02 0.15 ABDOMINAL PAIN | 4 0.04 0.19 ABDOMINAL PAIN UPPER | 2 0.02 0.21 ABDOMINOPLASTY | 1 0.01 0.22 ABNORMAL BEHAVIOUR | 1 0.01 0.23 ABSCESS | 2 0.02 0.25 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 0.26 ACCIDENTAL EXPOSURE | 5 0.05 0.31 ACNE | 30 0.30 0.61 ACNE CONGLOBATA | 1 0.01 0.62 ACQUIRED HAEMOPHILIA | 8 0.08 0.70 ACROMEGALY | 3 0.03 0.73 ACTINIC KERATOSIS | 3 0.03 0.76 ACUTE CORONARY SYNDROME | 12 0.12 0.88 ACUTE LEUKAEMIA | 1 0.01 0.89 ACUTE LYMPHOCYTIC LEUKAEMIA | 6 0.06 0.95 ACUTE MYELOID LEUKAEMIA | 18 0.18 1.13 ACUTE MYELOMONOCYTIC LEUKAEMIA | 6 0.06 1.19 ACUTE MYOCARDIAL INFARCTION | 26 0.26 1.45 ACUTE RESPIRATORY DISTRESS SYNDROME | 4 0.04 1.49 ADENOCARCINOMA PANCREAS | 2 0.02 1.51 ADJUSTMENT DISORDER | 1 0.01 1.52 ADRENAL CARCINOMA | 2 0.02 1.54 ADRENAL DISORDER | 1 0.01 1.55 ADRENAL INSUFFICIENCY | 6 0.06 1.61 ADRENOCORTICAL CARCINOMA | 1 0.01 1.62 ADULT T-CELL LYMPHOMA/LEUKAEMIA | 1 0.01 1.63 ADVERSE DRUG REACTION | 1 0.01 1.64 AFFECTIVE DISORDER | 5 0.05 1.69 AGGRESSION | 2 0.02 1.71 AGITATION | 6 0.06 1.77 ALCOHOL USE | 2 0.02 1.79 ALCOHOLISM | 1 0.01 1.80 ALOPECIA AREATA | 1 0.01 1.81 ALPHA-1 ANTI-TRYPSIN DEFICIENCY | 1 0.01 1.82 AMINO ACID LEVEL DECREASED | 1 0.01 1.83 AMNESIA | 1 0.01 1.84 AMYLOIDOSIS | 3 0.03 1.87 ANAEMIA | 19 0.19 2.06 ANAEMIA OF MALIGNANT DISEASE | 4 0.04 2.10 ANAEMIA PROPHYLAXIS | 1 0.01 2.11 ANAESTHESIA | 9 0.09 2.20 ANALGESIA | 8 0.08 2.28 ANALGESIC INTERVENTION SUPPORTIVE THE.. | 1 0.01 2.29 ANALGESIC THERAPY | 6 0.06 2.35 ANGINA PECTORIS | 10 0.10 2.45 ANGINA UNSTABLE | 2 0.02 2.47 ANGIOGRAM | 7 0.07 2.54 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA | 2 0.02 2.56 ANGIOPATHY | 2 0.02 2.58 ANGIOSARCOMA | 1 0.01 2.59 ANIMAL BITE | 2 0.02 2.61 ANKYLOSING SPONDYLITIS | 21 0.21 2.82 ANOGENITAL WARTS | 1 0.01 2.83 ANOREXIA | 4 0.04 2.87 ANTIALLERGIC THERAPY | 3 0.03 2.90 ANTIBIOTIC PROPHYLAXIS | 5 0.05 2.95 ANTIBIOTIC THERAPY | 4 0.04 2.99 ANTICOAGULANT THERAPY | 4 0.04 3.03 ANTIDEPRESSANT THERAPY | 2 0.02 3.05 ANTIEMETIC SUPPORTIVE CARE | 1 0.01 3.06 ANTIFUNGAL PROPHYLAXIS | 19 0.19 3.25 ANTIINFLAMMATORY THERAPY | 2 0.02 3.27 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 3.28 ANTIPLATELET THERAPY | 1 0.01 3.29 ANTIPYRESIS | 2 0.02 3.31 ANTIRETROVIRAL THERAPY | 10 0.10 3.41 ANTITUSSIVE THERAPY | 1 0.01 3.42 ANTIVIRAL PROPHYLAXIS | 7 0.07 3.49 ANURIA | 1 0.01 3.50 ANXIETY | 68 0.68 4.18 ANXIETY DISORDER | 2 0.02 4.20 ANXIOLYTIC THERAPY | 1 0.01 4.21 AORTIC ANEURYSM | 1 0.01 4.22 AORTIC DILATATION | 1 0.01 4.23 AORTIC VALVE REPLACEMENT | 1 0.01 4.24 APATHY | 1 0.01 4.25 APLASIA PURE RED CELL | 1 0.01 4.26 APLASTIC ANAEMIA | 2 0.02 4.28 ARRHYTHMIA | 7 0.07 4.35 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 4.36 ARTERIAL DISORDER | 1 0.01 4.37 ARTERIOGRAM CORONARY | 1 0.01 4.38 ARTERIOSCLEROSIS | 3 0.03 4.41 ARTERIOSCLEROSIS OBLITERANS | 3 0.03 4.44 ARTERITIS | 1 0.01 4.45 ARTHRALGIA | 24 0.24 4.69 ARTHRITIS | 27 0.27 4.96 ARTHROPATHY | 1 0.01 4.97 ARTHROPOD BITE | 2 0.02 4.99 ASCITES | 5 0.05 5.04 ASPERGER'S DISORDER | 1 0.01 5.05 ASPERGILLOSIS | 1 0.01 5.06 ASTHENIA | 3 0.03 5.09 ASTHMA | 109 1.09 6.18 ATRIAL FIBRILLATION | 28 0.28 6.46 ATROPHIC VULVOVAGINITIS | 1 0.01 6.47 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 19 0.19 6.66 ATYPICAL BENIGN PARTIAL EPILEPSY | 1 0.01 6.67 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 6.68 AUTISM | 2 0.02 6.70 AUTOIMMUNE DISORDER | 1 0.01 6.71 AUTOIMMUNE THYROIDITIS | 4 0.04 6.75 B-CELL LYMPHOMA | 20 0.20 6.95 BABESIOSIS | 2 0.02 6.97 BACK DISORDER | 1 0.01 6.98 BACK PAIN | 60 0.60 7.58 BACTERAEMIA | 1 0.01 7.59 BACTERIAL INFECTION | 2 0.02 7.61 BEHCET'S SYNDROME | 1 0.01 7.62 BENIGN PROSTATIC HYPERPLASIA | 33 0.33 7.95 BILE DUCT CANCER | 3 0.03 7.98 BILE DUCT CANCER STAGE IV | 1 0.01 7.99 BILIARY CIRRHOSIS PRIMARY | 1 0.01 8.00 BIPOLAR DISORDER | 49 0.49 8.49 BIPOLAR I DISORDER | 8 0.08 8.57 BIPOLAR II DISORDER | 1 0.01 8.58 BLADDER CANCER | 7 0.07 8.65 BLADDER DISCOMFORT | 1 0.01 8.66 BLADDER DISORDER | 5 0.05 8.71 BLEPHAROSPASM | 3 0.03 8.74 BLOOD ALBUMIN DECREASED | 1 0.01 8.75 BLOOD CALCIUM | 1 0.01 8.76 BLOOD CHOLESTEROL | 30 0.30 9.06 BLOOD CHOLESTEROL DECREASED | 1 0.01 9.07 BLOOD CHOLESTEROL INCREASED | 77 0.77 9.84 BLOOD GLUCOSE | 1 0.01 9.85 BLOOD GLUCOSE DECREASED | 1 0.01 9.86 BLOOD GLUCOSE INCREASED | 4 0.04 9.90 BLOOD INSULIN | 1 0.01 9.91 BLOOD MAGNESIUM DECREASED | 2 0.02 9.93 BLOOD PHOSPHORUS ABNORMAL | 1 0.01 9.94 BLOOD PHOSPHORUS DECREASED | 1 0.01 9.95 BLOOD POTASSIUM | 1 0.01 9.96 BLOOD POTASSIUM DECREASED | 2 0.02 9.98 BLOOD PRESSURE | 16 0.16 10.14 BLOOD PRESSURE ABNORMAL | 2 0.02 10.16 BLOOD PRESSURE INCREASED | 12 0.12 10.28 BLOOD PRESSURE MANAGEMENT | 2 0.02 10.30 BLOOD TESTOSTERONE DECREASED | 1 0.01 10.31 BLOOD TRIGLYCERIDES | 2 0.02 10.33 BLOOD TRIGLYCERIDES INCREASED | 39 0.39 10.72 BLOOD URIC ACID INCREASED | 1 0.01 10.73 BODY HEIGHT BELOW NORMAL | 2 0.02 10.75 BODY TEMPERATURE INCREASED | 1 0.01 10.76 BONE DISORDER | 9 0.09 10.85 BONE MARROW CONDITIONING REGIMEN | 3 0.03 10.88 BONE MARROW FAILURE | 1 0.01 10.89 BONE MARROW TRANSPLANT | 7 0.07 10.96 BONE NEOPLASM MALIGNANT | 1 0.01 10.97 BONE PAIN | 2 0.02 10.99 BONE SARCOMA | 4 0.04 11.03 BOWEL PREPARATION | 2 0.02 11.05 BRAIN ABSCESS | 1 0.01 11.06 BRAIN NEOPLASM | 2 0.02 11.08 BRAIN OEDEMA | 1 0.01 11.09 BREAKTHROUGH PAIN | 6 0.06 11.15 BREAST CANCER | 121 1.21 12.36 BREAST CANCER FEMALE | 2 0.02 12.38 BREAST CANCER METASTATIC | 25 0.25 12.63 BRONCHIAL CARCINOMA | 3 0.03 12.66 BRONCHIAL IRRITATION | 1 0.01 12.67 BRONCHIECTASIS | 2 0.02 12.69 BRONCHIOLITIS | 2 0.02 12.71 BRONCHITIS | 25 0.25 12.96 BRONCHOPNEUMONIA | 6 0.06 13.02 BRONCHOPULMONARY ASPERGILLOSIS | 3 0.03 13.05 BRONCHOSPASM | 5 0.05 13.10 BULLOUS IMPETIGO | 2 0.02 13.12 BURKITT'S LYMPHOMA | 1 0.01 13.13 CAESAREAN SECTION | 2 0.02 13.15 CALCIUM DEFICIENCY | 1 0.01 13.16 CALCULUS URETERIC | 1 0.01 13.17 CANCER PAIN | 19 0.19 13.36 CANDIDIASIS | 4 0.04 13.40 CARCINOID SYNDROME | 1 0.01 13.41 CARCINOID TUMOUR | 7 0.07 13.48 CARDIAC DISORDER | 22 0.22 13.70 CARDIAC FAILURE | 23 0.23 13.93 CARDIAC FAILURE CONGESTIVE | 15 0.15 14.08 CARDIAC FIBRILLATION | 1 0.01 14.09 CARDIAC FLUTTER | 1 0.01 14.10 CARDIAC HYPERTROPHY | 1 0.01 14.11 CARDIAC OPERATION | 4 0.04 14.15 CARDIOVASCULAR DISORDER | 2 0.02 14.17 CARDIOVASCULAR EVENT PROPHYLAXIS | 2 0.02 14.19 CAROTID ARTERIOSCLEROSIS | 1 0.01 14.20 CAROTID ARTERY STENOSIS | 1 0.01 14.21 CATHETER SEPSIS | 1 0.01 14.22 CATHETERISATION CARDIAC | 1 0.01 14.23 CELLULITIS | 4 0.04 14.27 CEREBRAL HAEMORRHAGE | 1 0.01 14.28 CEREBRAL INFARCTION | 9 0.09 14.37 CEREBRAL ISCHAEMIA | 1 0.01 14.38 CEREBRAL PALSY | 1 0.01 14.39 CEREBRAL VENOUS THROMBOSIS | 2 0.02 14.41 CEREBROVASCULAR ACCIDENT | 8 0.08 14.49 CEREBROVASCULAR ACCIDENT PROPHYLAXIS | 3 0.03 14.52 CERVICOBRACHIAL SYNDROME | 5 0.05 14.57 CERVIX CARCINOMA | 5 0.05 14.62 CHEMOTHERAPY | 19 0.19 14.81 CHEST DISCOMFORT | 1 0.01 14.82 CHEST PAIN | 4 0.04 14.86 CHILLS | 1 0.01 14.87 CHOLELITHIASIS | 4 0.04 14.91 CHOLESTASIS | 1 0.01 14.92 CHONDRODYSTROPHY | 1 0.01 14.93 CHOROIDAL NEOVASCULARISATION | 8 0.08 15.01 CHRONIC HEPATITIS | 1 0.01 15.02 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 15.03 CHRONIC LYMPHOCYTIC LEUKAEMIA | 9 0.09 15.12 CHRONIC MYELOID LEUKAEMIA | 30 0.30 15.42 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 89 0.89 16.31 CHRONIC RESPIRATORY DISEASE | 1 0.01 16.32 CHRONIC RESPIRATORY FAILURE | 1 0.01 16.33 CHRONIC SINUSITIS | 1 0.01 16.34 COAGULOPATHY | 3 0.03 16.37 COELIAC DISEASE | 1 0.01 16.38 COLITIS | 1 0.01 16.39 COLITIS ULCERATIVE | 30 0.30 16.69 COLON CANCER | 27 0.27 16.96 COLONOSCOPY | 2 0.02 16.98 COLORECTAL CANCER | 29 0.29 17.27 COLORECTAL CANCER METASTATIC | 26 0.26 17.53 COMBINED IMMUNODEFICIENCY | 1 0.01 17.54 COMPUTERISED TOMOGRAM | 2 0.02 17.56 COMPUTERISED TOMOGRAM ABDOMEN | 5 0.05 17.61 CONDITION AGGRAVATED | 1 0.01 17.62 CONFUSIONAL STATE | 2 0.02 17.64 CONJUNCTIVITIS | 6 0.06 17.70 CONJUNCTIVOPLASTY | 2 0.02 17.72 CONSTIPATION | 42 0.42 18.14 CONTRACEPTION | 149 1.49 19.63 CONVULSION | 24 0.24 19.87 CONVULSION PROPHYLAXIS | 7 0.07 19.94 CORD BLOOD TRANSPLANT THERAPY | 8 0.08 20.02 CORONARY ANGIOPLASTY | 1 0.01 20.03 CORONARY ARTERIAL STENT INSERTION | 4 0.04 20.07 CORONARY ARTERY BYPASS | 1 0.01 20.08 CORONARY ARTERY DISEASE | 3 0.03 20.11 CORONARY ARTERY INSUFFICIENCY | 3 0.03 20.14 COUGH | 15 0.15 20.29 CROHN'S DISEASE | 84 0.84 21.13 CRYPTOGENIC CIRRHOSIS | 2 0.02 21.15 CYSTITIS | 6 0.06 21.21 CYTOMEGALOVIRUS INFECTION | 1 0.01 21.22 CYTOMEGALOVIRUS TEST | 1 0.01 21.23 DEBRIDEMENT | 1 0.01 21.24 DECREASED APPETITE | 2 0.02 21.26 DEEP VEIN THROMBOSIS | 12 0.12 21.38 DEHYDRATION | 3 0.03 21.41 DELIRIUM | 1 0.01 21.42 DELUSION | 2 0.02 21.44 DEMENTIA | 5 0.05 21.49 DEMENTIA ALZHEIMER'S TYPE | 14 0.14 21.63 DEMENTIA OF THE ALZHEIMER'S TYPE, WIT.. | 2 0.02 21.65 DEMENTIA WITH LEWY BODIES | 1 0.01 21.66 DEMYELINATION | 1 0.01 21.67 DENTAL CARE | 1 0.01 21.68 DENTAL DISORDER PROPHYLAXIS | 1 0.01 21.69 DEPENDENCE | 1 0.01 21.70 DEPRESSED MOOD | 1 0.01 21.71 DEPRESSION | 203 2.03 23.74 DERMATITIS ALLERGIC | 5 0.05 23.79 DERMATITIS ATOPIC | 1 0.01 23.80 DERMATITIS HERPETIFORMIS | 1 0.01 23.81 DESMOID TUMOUR | 3 0.03 23.84 DEVELOPMENTAL GLAUCOMA | 1 0.01 23.85 DEVICE RELATED INFECTION | 1 0.01 23.86 DIABETES INSIPIDUS | 2 0.02 23.88 DIABETES MELLITUS | 228 2.28 26.16 DIABETIC FOOT | 1 0.01 26.17 DIABETIC GASTROPARESIS | 1 0.01 26.18 DIABETIC NEPHROPATHY | 1 0.01 26.19 DIABETIC NEUROPATHY | 4 0.04 26.23 DIABETIC RETINAL OEDEMA | 1 0.01 26.24 DIAGNOSTIC PROCEDURE | 1 0.01 26.25 DIALYSIS | 14 0.14 26.39 DIARRHOEA | 20 0.20 26.59 DIFFUSE LARGE B-CELL LYMPHOMA | 29 0.29 26.88 DISEASE PROGRESSION | 1 0.01 26.89 DISEASE RECURRENCE | 1 0.01 26.90 DISORIENTATION | 1 0.01 26.91 DIURETIC THERAPY | 8 0.08 26.99 DIVERTICULITIS | 2 0.02 27.01 DRUG ABUSE | 2 0.02 27.03 DRUG DEPENDENCE | 1 0.01 27.04 DRUG EFFECT DECREASED | 2 0.02 27.06 DRUG ERUPTION | 1 0.01 27.07 DRUG EXPOSURE DURING PREGNANCY | 40 0.40 27.47 DRUG HYPERSENSITIVITY | 1 0.01 27.48 DRUG THERAPY | 6 0.06 27.54 DRUG USE FOR UNKNOWN INDICATION | 1,980 19.80 47.34 DRY EYE | 3 0.03 47.37 DRY SKIN | 1 0.01 47.38 DUODENAL ULCER | 2 0.02 47.40 DYSKINESIA | 2 0.02 47.42 DYSLIPIDAEMIA | 16 0.16 47.58 DYSMENORRHOEA | 5 0.05 47.63 DYSPEPSIA | 21 0.21 47.84 DYSPNOEA | 9 0.09 47.93 DYSTHYMIC DISORDER | 2 0.02 47.95 DYSTONIA | 1 0.01 47.96 DYSURIA | 5 0.05 48.01 EAR PAIN | 2 0.02 48.03 EATING DISORDER | 1 0.01 48.04 ECHOCARDIOGRAM | 1 0.01 48.05 ECZEMA | 4 0.04 48.09 EMBOLISM | 1 0.01 48.10 EMPHYSEMA | 9 0.09 48.19 ENDOCARDITIS | 4 0.04 48.23 ENDOCARDITIS PROPHYLAXIS | 1 0.01 48.24 ENDODONTIC PROCEDURE | 2 0.02 48.26 ENDOMETRIOSIS | 4 0.04 48.30 ENDOSCOPY | 1 0.01 48.31 ENTEROBACTER INFECTION | 1 0.01 48.32 ENTEROCOLITIS | 1 0.01 48.33 ENURESIS | 3 0.03 48.36 EPIDURAL ANAESTHESIA | 6 0.06 48.42 EPILEPSY | 43 0.43 48.85 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 2 0.02 48.87 ERECTILE DYSFUNCTION | 16 0.16 49.03 ERYTHEMA | 2 0.02 49.05 ESSENTIAL HYPERTENSION | 14 0.14 49.19 EVIDENCE BASED TREATMENT | 4 0.04 49.23 EX-TOBACCO USER | 2 0.02 49.25 EYE DISORDER | 1 0.01 49.26 EYE LASER SURGERY | 1 0.01 49.27 FABRY'S DISEASE | 6 0.06 49.33 FACIAL SPASM | 3 0.03 49.36 FACTOR IX DEFICIENCY | 1 0.01 49.37 FACTOR V LEIDEN MUTATION | 1 0.01 49.38 FALLOPIAN TUBE CANCER | 1 0.01 49.39 FEBRILE CONVULSION | 2 0.02 49.41 FEBRILE NEUTROPENIA | 7 0.07 49.48 FIBROMYALGIA | 17 0.17 49.65 FISTULA | 1 0.01 49.66 FLATULENCE | 1 0.01 49.67 FLUID OVERLOAD | 1 0.01 49.68 FLUID REPLACEMENT | 3 0.03 49.71 FLUID RETENTION | 6 0.06 49.77 FLUSHING | 1 0.01 49.78 FOETAL CARDIAC DISORDER | 2 0.02 49.80 FOETAL THERAPEUTIC PROCEDURE | 1 0.01 49.81 FOLATE DEFICIENCY | 1 0.01 49.82 FOLLICULITIS | 5 0.05 49.87 FOOT DEFORMITY | 1 0.01 49.88 FRACTURE | 1 0.01 49.89 FUNGAL INFECTION | 10 0.10 49.99 GALLBLADDER CANCER | 3 0.03 50.02 GASTRIC BYPASS | 1 0.01 50.03 GASTRIC CANCER | 30 0.30 50.33 GASTRIC DISORDER | 4 0.04 50.37 GASTRIC PH DECREASED | 1 0.01 50.38 GASTRIC ULCER | 18 0.18 50.56 GASTRITIS | 21 0.21 50.77 GASTRITIS PROPHYLAXIS | 3 0.03 50.80 GASTROENTERITIS | 1 0.01 50.81 GASTROINTESTINAL CANDIDIASIS | 2 0.02 50.83 GASTROINTESTINAL CARCINOMA | 2 0.02 50.85 GASTROINTESTINAL DISORDER | 15 0.15 51.00 GASTROINTESTINAL HAEMORRHAGE | 2 0.02 51.02 GASTROINTESTINAL INFECTION | 1 0.01 51.03 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 51.05 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 51.06 GASTROINTESTINAL NEOPLASM | 2 0.02 51.08 GASTROINTESTINAL STROMAL TUMOUR | 15 0.15 51.23 GASTROOESOPHAGEAL REFLUX DISEASE | 44 0.44 51.67 GAUCHER'S DISEASE | 3 0.03 51.70 GENERALISED ANXIETY DISORDER | 1 0.01 51.71 GENITAL HERPES | 2 0.02 51.73 GESTATIONAL DIABETES | 5 0.05 51.78 GIARDIASIS | 1 0.01 51.79 GLAUCOMA | 22 0.22 52.01 GLIOBLASTOMA MULTIFORME | 16 0.16 52.17 GLOMERULONEPHRITIS | 1 0.01 52.18 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE | 1 0.01 52.19 GLYCOGEN STORAGE DISEASE TYPE II | 2 0.02 52.21 GOUT | 5 0.05 52.26 GRAFT VERSUS HOST DISEASE | 3 0.03 52.29 GROWTH HORMONE DEFICIENCY | 5 0.05 52.34 GROWTH RETARDATION | 1 0.01 52.35 GYNAECOMASTIA | 1 0.01 52.36 HAEMANGIOMA | 1 0.01 52.37 HAEMATOPOIETIC STEM CELL MOBILISATION | 4 0.04 52.41 HAEMODIALYSIS | 1 0.01 52.42 HAEMODIALYSIS-INDUCED SYMPTOM | 1 0.01 52.43 HAEMOPHILIA A WITH ANTI FACTOR VIII | 1 0.01 52.44 HAEMORRHAGE | 2 0.02 52.46 HAEMORRHOIDS | 2 0.02 52.48 HAEMOSIDEROSIS | 2 0.02 52.50 HALLUCINATION | 5 0.05 52.55 HALLUCINATION, OLFACTORY | 1 0.01 52.56 HEAD AND NECK CANCER | 13 0.13 52.69 HEAD INJURY | 1 0.01 52.70 HEADACHE | 11 0.11 52.81 HEART RATE INCREASED | 2 0.02 52.83 HEART RATE IRREGULAR | 1 0.01 52.84 HEART TRANSPLANT | 9 0.09 52.93 HELICOBACTER INFECTION | 5 0.05 52.98 HEPARIN-INDUCED THROMBOCYTOPENIA | 1 0.01 52.99 HEPATIC ADENOMA | 2 0.02 53.01 HEPATIC CANCER METASTATIC | 3 0.03 53.04 HEPATIC CIRRHOSIS | 8 0.08 53.12 HEPATIC NEOPLASM MALIGNANT | 13 0.13 53.25 HEPATITIS B | 4 0.04 53.29 HEPATITIS B ANTIBODY POSITIVE | 1 0.01 53.30 HEPATITIS B ANTIGEN POSITIVE | 1 0.01 53.31 HEPATITIS B SURFACE ANTIGEN POSITIVE | 1 0.01 53.32 HEPATITIS C | 53 0.53 53.85 HEPATITIS C POSITIVE | 2 0.02 53.87 HEPATITIS C VIRUS TEST | 6 0.06 53.93 HEPATITIS NON-A NON-B | 1 0.01 53.94 HERPES SIMPLEX | 1 0.01 53.95 HERPES VIRUS INFECTION | 4 0.04 53.99 HERPES ZOSTER | 8 0.08 54.07 HIATUS HERNIA | 6 0.06 54.13 HIGH DENSITY LIPOPROTEIN DECREASED | 3 0.03 54.16 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 54.17 HISTIOCYTOSIS HAEMATOPHAGIC | 5 0.05 54.22 HIV INFECTION | 260 2.60 56.82 HIV TEST POSITIVE | 2 0.02 56.84 HORMONE LEVEL ABNORMAL | 2 0.02 56.86 HORMONE REPLACEMENT THERAPY | 35 0.35 57.21 HORMONE SUPPRESSION THERAPY | 1 0.01 57.22 HORMONE THERAPY | 1 0.01 57.23 HOT FLUSH | 4 0.04 57.27 HOUSE DUST ALLERGY | 1 0.01 57.28 HUMAN IMMUNODEFICIENCY VIRUS TRANSMIS.. | 16 0.16 57.44 HUNGER | 1 0.01 57.45 HYPERCALCAEMIA | 3 0.03 57.48 HYPERCALCAEMIA OF MALIGNANCY | 1 0.01 57.49 HYPERCHLORHYDRIA | 1 0.01 57.50 HYPERCHOLESTEROLAEMIA | 51 0.51 58.01 HYPERGLYCAEMIA | 1 0.01 58.02 HYPERKALAEMIA | 2 0.02 58.04 HYPERKERATOSIS | 1 0.01 58.05 HYPERLIPIDAEMIA | 28 0.28 58.33 HYPERPARATHYROIDISM SECONDARY | 6 0.06 58.39 HYPERPHOSPHATAEMIA | 1 0.01 58.40 HYPERPROLACTINAEMIA | 1 0.01 58.41 HYPERSENSITIVITY | 17 0.17 58.58 HYPERTENSION | 370 3.70 62.28 HYPERTHYROIDISM | 3 0.03 62.31 HYPERTONIA | 2 0.02 62.33 HYPERTONIC BLADDER | 9 0.09 62.42 HYPERTRIGLYCERIDAEMIA | 5 0.05 62.47 HYPERTROPHIC CARDIOMYOPATHY | 4 0.04 62.51 HYPERURICAEMIA | 6 0.06 62.57 HYPOAESTHESIA | 1 0.01 62.58 HYPOCALCAEMIA | 1 0.01 62.59 HYPOGAMMAGLOBULINAEMIA | 1 0.01 62.60 HYPOGLYCAEMIA | 1 0.01 62.61 HYPOGONADISM | 1 0.01 62.62 HYPOKALAEMIA | 3 0.03 62.65 HYPOPHAGIA | 5 0.05 62.70 HYPOPITUITARISM | 3 0.03 62.73 HYPOPROTEINAEMIA | 1 0.01 62.74 HYPOTENSION | 2 0.02 62.76 HYPOTHYROIDISM | 50 0.50 63.26 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 63.27 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 1 0.01 63.28 ILIAC ARTERY OCCLUSION | 1 0.01 63.29 ILL-DEFINED DISORDER | 4 0.04 63.33 ILLUSION | 1 0.01 63.34 IMMUNISATION | 1 0.01 63.35 IMMUNOMODULATORY THERAPY | 1 0.01 63.36 IMMUNOSUPPRESSANT DRUG THERAPY | 8 0.08 63.44 IMMUNOSUPPRESSION | 19 0.19 63.63 IMPAIRED GASTRIC EMPTYING | 1 0.01 63.64 IMPAIRED HEALING | 1 0.01 63.65 IMPLANT SITE INFECTION | 1 0.01 63.66 IN VITRO FERTILISATION | 7 0.07 63.73 INCREASED BRONCHIAL SECRETION | 2 0.02 63.75 INCREASED UPPER AIRWAY SECRETION | 1 0.01 63.76 INDUCED LABOUR | 1 0.01 63.77 INDUCTION OF ANAESTHESIA | 3 0.03 63.80 INDWELLING CATHETER MANAGEMENT | 1 0.01 63.81 INFECTION | 23 0.23 64.04 INFECTION PARASITIC | 1 0.01 64.05 INFECTION PROPHYLAXIS | 16 0.16 64.21 INFLAMMATION | 5 0.05 64.26 INFLAMMATORY BOWEL DISEASE | 2 0.02 64.28 INFLUENZA | 5 0.05 64.33 INITIAL INSOMNIA | 1 0.01 64.34 INSOMNIA | 71 0.71 65.05 INSULIN RESISTANT DIABETES | 1 0.01 65.06 INSULIN-REQUIRING TYPE 2 DIABETES MEL.. | 19 0.19 65.25 INTERSTITIAL LUNG DISEASE | 3 0.03 65.28 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 65.29 INTERVERTEBRAL DISC DISORDER | 4 0.04 65.33 INTERVERTEBRAL DISC PROTRUSION | 8 0.08 65.41 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 65.42 INTRAOCULAR PRESSURE INCREASED | 3 0.03 65.45 INTRAOCULAR PRESSURE TEST | 1 0.01 65.46 INTRAVENOUS CATHETER MANAGEMENT | 1 0.01 65.47 IRON DEFICIENCY | 1 0.01 65.48 IRON DEFICIENCY ANAEMIA | 8 0.08 65.56 IRON OVERLOAD | 15 0.15 65.71 IRRITABLE BOWEL SYNDROME | 7 0.07 65.78 ISCHAEMIC CARDIOMYOPATHY | 1 0.01 65.79 ISCHAEMIC HEART DISEASE PROPHYLAXIS | 1 0.01 65.80 JOINT INJURY | 2 0.02 65.82 JOINT SWELLING | 1 0.01 65.83 JUVENILE ARTHRITIS | 25 0.25 66.08 KAPOSI'S SARCOMA | 2 0.02 66.10 KERATOCONJUNCTIVITIS SICCA | 1 0.01 66.11 KIDNEY TRANSPLANT REJECTION | 4 0.04 66.15 LABOUR INDUCTION | 1 0.01 66.16 LACTOSE INTOLERANCE | 1 0.01 66.17 LARGE INTESTINE CARCINOMA | 5 0.05 66.22 LARYNGEAL CANCER | 3 0.03 66.25 LEPROMATOUS LEPROSY | 2 0.02 66.27 LEUKAEMIA | 6 0.06 66.33 LEUKAEMIA PLASMACYTIC | 4 0.04 66.37 LEUKOPENIA | 1 0.01 66.38 LIMB INJURY | 1 0.01 66.39 LIPIDS ABNORMAL | 2 0.02 66.41 LIPIDS INCREASED | 1 0.01 66.42 LIPODYSTROPHY ACQUIRED | 1 0.01 66.43 LIVER TRANSPLANT | 12 0.12 66.55 LOCAL ANAESTHESIA | 6 0.06 66.61 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 66.63 LOWER RESPIRATORY TRACT INFECTION | 1 0.01 66.64 LUMBAR RADICULOPATHY | 1 0.01 66.65 LUNG ADENOCARCINOMA | 2 0.02 66.67 LUNG ADENOCARCINOMA RECURRENT | 2 0.02 66.69 LUNG CANCER METASTATIC | 2 0.02 66.71 LUNG CARCINOMA CELL TYPE UNSPECIFIED .. | 1 0.01 66.72 LUNG DISORDER | 3 0.03 66.75 LUNG INFECTION | 2 0.02 66.77 LUNG LOBECTOMY | 1 0.01 66.78 LUNG NEOPLASM | 4 0.04 66.82 LUNG NEOPLASM MALIGNANT | 13 0.13 66.95 LUNG TRANSPLANT | 4 0.04 66.99 LUPUS ENCEPHALITIS | 2 0.02 67.01 LYMPHADENITIS | 1 0.01 67.02 LYMPHADENOPATHY | 3 0.03 67.05 LYMPHOCYTIC LYMPHOMA | 1 0.01 67.06 LYMPHOMA | 5 0.05 67.11 MACULAR DEGENERATION | 14 0.14 67.25 MACULAR OEDEMA | 1 0.01 67.26 MAINTENANCE OF ANAESTHESIA | 2 0.02 67.28 MAJOR DEPRESSION | 8 0.08 67.36 MALARIA | 2 0.02 67.38 MALARIA PROPHYLAXIS | 3 0.03 67.41 MALIGNANT MELANOMA | 7 0.07 67.48 MALIGNANT NEOPLASM OF RENAL PELVIS | 1 0.01 67.49 MALNUTRITION | 3 0.03 67.52 MANIA | 4 0.04 67.56 MASTOCYTOSIS | 1 0.01 67.57 MEASLES | 1 0.01 67.58 MEDICAL DEVICE COMPLICATION | 3 0.03 67.61 MEDICAL DIET | 6 0.06 67.67 MEDICATION DILUTION | 1 0.01 67.68 MEIBOMIANITIS | 1 0.01 67.69 MENIERE'S DISEASE | 2 0.02 67.71 MENINGITIS | 1 0.01 67.72 MENINGITIS FUNGAL | 1 0.01 67.73 MENOPAUSAL SYMPTOMS | 7 0.07 67.80 MENOPAUSE | 4 0.04 67.84 MENORRHAGIA | 4 0.04 67.88 MENSTRUAL DISORDER | 3 0.03 67.91 MENSTRUATION IRREGULAR | 1 0.01 67.92 MENTAL DISORDER | 4 0.04 67.96 METASTASES TO BONE | 14 0.14 68.10 METASTASES TO LIVER | 1 0.01 68.11 METASTASES TO LUNG | 1 0.01 68.12 METASTASIS | 1 0.01 68.13 METASTATIC PAIN | 11 0.11 68.24 METASTATIC RENAL CELL CARCINOMA | 20 0.20 68.44 MICROSPORIDIA INFECTION | 1 0.01 68.45 MICTURITION URGENCY | 1 0.01 68.46 MIDDLE INSOMNIA | 1 0.01 68.47 MIGRAINE | 26 0.26 68.73 MIGRAINE PROPHYLAXIS | 3 0.03 68.76 MINERAL SUPPLEMENTATION | 7 0.07 68.83 MITRAL VALVE PROLAPSE | 1 0.01 68.84 MITRAL VALVE REPLACEMENT | 1 0.01 68.85 MIXED HYPERLIPIDAEMIA | 2 0.02 68.87 MONARTHRITIS | 1 0.01 68.88 MOOD ALTERED | 1 0.01 68.89 MOOD SWINGS | 3 0.03 68.92 MUCOPOLYSACCHARIDOSIS I | 1 0.01 68.93 MUCOPOLYSACCHARIDOSIS II | 1 0.01 68.94 MULTIPLE ALLERGIES | 11 0.11 69.05 MULTIPLE MYELOMA | 94 0.94 69.99 MULTIPLE SCLEROSIS | 101 1.01 71.00 MUSCLE CONTRACTURE | 1 0.01 71.01 MUSCLE DISORDER | 2 0.02 71.03 MUSCLE RELAXANT THERAPY | 4 0.04 71.07 MUSCLE SPASMS | 6 0.06 71.13 MUSCLE SPASTICITY | 8 0.08 71.21 MUSCULOSKELETAL PAIN | 17 0.17 71.38 MUSCULOSKELETAL STIFFNESS | 1 0.01 71.39 MYALGIA | 4 0.04 71.43 MYASTHENIA GRAVIS | 1 0.01 71.44 MYCOSIS FUNGOIDES | 3 0.03 71.47 MYELODYSPLASTIC SYNDROME | 21 0.21 71.68 MYELOFIBROSIS | 2 0.02 71.70 MYOCARDIAL INFARCTION | 8 0.08 71.78 MYOCARDIAL ISCHAEMIA | 8 0.08 71.86 MYOCLONUS | 2 0.02 71.88 NARCOLEPSY | 2 0.02 71.90 NASAL CONGESTION | 2 0.02 71.92 NASOPHARYNGEAL CANCER | 1 0.01 71.93 NASOPHARYNGITIS | 18 0.18 72.11 NAUSEA | 31 0.31 72.42 NECK PAIN | 9 0.09 72.51 NEOPLASM | 1 0.01 72.52 NEOPLASM MALIGNANT | 14 0.14 72.66 NEPHROBLASTOMA | 1 0.01 72.67 NERVE INJURY | 3 0.03 72.70 NERVOUS SYSTEM DISORDER | 1 0.01 72.71 NERVOUSNESS | 1 0.01 72.72 NEURALGIA | 18 0.18 72.90 NEUROGENIC BLADDER | 1 0.01 72.91 NEUROMA | 1 0.01 72.92 NEUROMUSCULAR BLOCKING THERAPY | 1 0.01 72.93 NEUROPATHY PERIPHERAL | 13 0.13 73.06 NEUTROPENIA | 4 0.04 73.10 NICOTINE DEPENDENCE | 3 0.03 73.13 NON-HODGKIN'S LYMPHOMA | 22 0.22 73.35 NON-HODGKIN'S LYMPHOMA REFRACTORY | 1 0.01 73.36 NON-SMALL CELL LUNG CANCER | 36 0.36 73.72 NON-SMALL CELL LUNG CANCER METASTATIC | 1 0.01 73.73 NON-SMALL CELL LUNG CANCER STAGE IV | 2 0.02 73.75 NORMAL TENSION GLAUCOMA | 2 0.02 73.77 NUCLEAR MAGNETIC RESONANCE IMAGING | 34 0.34 74.11 NUCLEAR MAGNETIC RESONANCE IMAGING AB.. | 1 0.01 74.12 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 5 0.05 74.17 NUTRITIONAL SUPPORT | 16 0.16 74.33 OBESITY | 13 0.13 74.46 OBSESSIVE THOUGHTS | 1 0.01 74.47 OBSESSIVE-COMPULSIVE DISORDER | 7 0.07 74.54 OEDEMA | 3 0.03 74.57 OEDEMA PERIPHERAL | 3 0.03 74.60 OESOPHAGEAL CANCER METASTATIC | 1 0.01 74.61 OESOPHAGEAL CANDIDIASIS | 1 0.01 74.62 OESOPHAGEAL CARCINOMA | 12 0.12 74.74 OESOPHAGEAL NEOPLASM | 3 0.03 74.77 OESOPHAGEAL SQUAMOUS CELL CARCINOMA S.. | 2 0.02 74.79 OESOPHAGEAL STENOSIS | 1 0.01 74.80 OESOPHAGITIS | 1 0.01 74.81 OESTROGEN REPLACEMENT THERAPY | 2 0.02 74.83 OFF LABEL USE | 9 0.09 74.92 ONCOLOGIC COMPLICATION | 4 0.04 74.96 ONYCHOMYCOSIS | 10 0.10 75.06 OPEN ANGLE GLAUCOMA | 1 0.01 75.07 OPEN WOUND | 1 0.01 75.08 OPPORTUNISTIC INFECTION PROPHYLAXIS | 3 0.03 75.11 OPSOCLONUS MYOCLONUS | 8 0.08 75.19 ORAL CANDIDIASIS | 1 0.01 75.20 ORAL CONTRACEPTION | 4 0.04 75.24 ORAL DISCOMFORT | 1 0.01 75.25 ORAL HERPES | 1 0.01 75.26 ORAL LICHEN PLANUS | 2 0.02 75.28 OROPHARYNGEAL CANCER RECURRENT | 3 0.03 75.31 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 4 0.04 75.35 OROPHARYNGEAL PAIN | 4 0.04 75.39 ORTHOPEDIC PROCEDURE | 1 0.01 75.40 OSTEITIS | 4 0.04 75.44 OSTEITIS DEFORMANS | 3 0.03 75.47 OSTEOARTHRITIS | 14 0.14 75.61 OSTEOMALACIA | 1 0.01 75.62 OSTEOMYELITIS | 2 0.02 75.64 OSTEOPENIA | 12 0.12 75.76 OSTEOPOROSIS | 137 1.37 77.13 OSTEOPOROSIS POSTMENOPAUSAL | 6 0.06 77.19 OSTEOPOROSIS PROPHYLAXIS | 6 0.06 77.25 OVARIAN CANCER | 14 0.14 77.39 OVARIAN CANCER RECURRENT | 2 0.02 77.41 OVARIAN EPITHELIAL CANCER | 3 0.03 77.44 PAIN | 158 1.58 79.02 PAIN IN EXTREMITY | 5 0.05 79.07 PAIN MANAGEMENT | 2 0.02 79.09 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 1 0.01 79.10 PALPITATIONS | 1 0.01 79.11 PANCREATIC CARCINOMA | 3 0.03 79.14 PANCREATIC CARCINOMA METASTATIC | 2 0.02 79.16 PANCREATITIS CHRONIC | 1 0.01 79.17 PANIC ATTACK | 3 0.03 79.20 PANIC DISORDER | 8 0.08 79.28 PANIC REACTION | 2 0.02 79.30 PARAESTHESIA | 3 0.03 79.33 PARALYSIS | 1 0.01 79.34 PARATHYROIDECTOMY | 1 0.01 79.35 PARENTERAL NUTRITION | 2 0.02 79.37 PARKINSON'S DISEASE | 76 0.76 80.13 PARKINSONISM | 5 0.05 80.18 PARONYCHIA | 1 0.01 80.19 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA | 2 0.02 80.21 PARTIAL SEIZURES | 1 0.01 80.22 PATERNAL DRUGS AFFECTING FOETUS | 2 0.02 80.24 PEMPHIGOID | 2 0.02 80.26 PEPTIC ULCER | 1 0.01 80.27 PERCUTANEOUS CORONARY INTERVENTION | 2 0.02 80.29 PERIARTHRITIS | 1 0.01 80.30 PERIPHERAL ISCHAEMIA | 3 0.03 80.33 PERITONEAL DIALYSIS | 63 0.63 80.96 PERITONITIS | 4 0.04 81.00 PETIT MAL EPILEPSY | 5 0.05 81.05 PHAEOCHROMOCYTOMA | 1 0.01 81.06 PHARYNGITIS | 2 0.02 81.08 PHLEBITIS | 1 0.01 81.09 PHOSPHORUS METABOLISM DISORDER | 1 0.01 81.10 PITUITARY TUMOUR BENIGN | 1 0.01 81.11 PITYRIASIS ROSEA | 1 0.01 81.12 PLATELET AGGREGATION | 1 0.01 81.13 PLEURAL EFFUSION | 1 0.01 81.14 PLEURAL MESOTHELIOMA | 2 0.02 81.16 PLEURAL MESOTHELIOMA MALIGNANT | 4 0.04 81.20 PNEUMOCYSTIS JIROVECI PNEUMONIA | 3 0.03 81.23 PNEUMONIA | 32 0.32 81.55 PNEUMONIA ASPIRATION | 11 0.11 81.66 PNEUMONIA KLEBSIELLA | 1 0.01 81.67 PNEUMONIA NECROTISING | 1 0.01 81.68 PNEUMONIA VIRAL | 1 0.01 81.69 PNEUMONITIS | 1 0.01 81.70 POLLAKIURIA | 2 0.02 81.72 POLYARTHRITIS | 7 0.07 81.79 POLYCYSTIC OVARIES | 1 0.01 81.80 POLYCYTHAEMIA VERA | 1 0.01 81.81 POLYMYALGIA RHEUMATICA | 4 0.04 81.85 POLYMYOSITIS | 1 0.01 81.86 POLYNEUROPATHY | 2 0.02 81.88 POLYURIA | 1 0.01 81.89 POOR QUALITY SLEEP | 1 0.01 81.90 POST HERPETIC NEURALGIA | 3 0.03 81.93 POST PROCEDURAL HAEMORRHAGE | 5 0.05 81.98 POST PROCEDURAL INFECTION | 1 0.01 81.99 POST-TRAUMATIC STRESS DISORDER | 4 0.04 82.03 POSTMENOPAUSE | 1 0.01 82.04 POSTNASAL DRIP | 1 0.01 82.05 POSTOPERATIVE CARE | 69 0.69 82.74 POSTPARTUM DEPRESSION | 5 0.05 82.79 PREGNANCY | 2 0.02 82.81 PREMATURE LABOUR | 6 0.06 82.87 PREMEDICATION | 77 0.77 83.64 PREMENSTRUAL SYNDROME | 5 0.05 83.69 PREOPERATIVE CARE | 34 0.34 84.03 PRIMARY MEDIASTINAL LARGE B-CELL LYMP.. | 5 0.05 84.08 PROCEDURAL PAIN | 7 0.07 84.15 PROCTITIS HAEMORRHAGIC | 1 0.01 84.16 PRODUCT CONTAMINATION | 1 0.01 84.17 PRODUCTIVE COUGH | 8 0.08 84.25 PROLACTINOMA | 1 0.01 84.26 PROMOTION OF PERIPHERAL CIRCULATION | 1 0.01 84.27 PROPHYLAXIS | 110 1.10 85.37 PROPHYLAXIS AGAINST GASTROINTESTINAL .. | 13 0.13 85.50 PROPHYLAXIS AGAINST GRAFT VERSUS HOST.. | 11 0.11 85.61 PROPHYLAXIS AGAINST TRANSPLANT REJECT.. | 14 0.14 85.75 PROPHYLAXIS OF NAUSEA AND VOMITING | 6 0.06 85.81 PROPHYLAXIS URINARY TRACT INFECTION | 2 0.02 85.83 PROSTATE CANCER | 39 0.39 86.22 PROSTATE CANCER METASTATIC | 6 0.06 86.28 PROSTATE CANCER STAGE I | 2 0.02 86.30 PROSTATE CANCER STAGE II | 9 0.09 86.39 PROSTATE CANCER STAGE III | 4 0.04 86.43 PROSTATE CANCER STAGE IV | 12 0.12 86.55 PROSTATIC ADENOMA | 1 0.01 86.56 PROSTATIC DISORDER | 2 0.02 86.58 PROSTATIC SPECIFIC ANTIGEN | 1 0.01 86.59 PROSTATISM | 2 0.02 86.61 PROSTATITIS | 1 0.01 86.62 PROSTATOMEGALY | 2 0.02 86.64 PROTEIN C DEFICIENCY | 2 0.02 86.66 PRURITUS | 9 0.09 86.75 PSORIASIS | 33 0.33 87.08 PSORIATIC ARTHROPATHY | 14 0.14 87.22 PSYCHOMOTOR HYPERACTIVITY | 3 0.03 87.25 PSYCHOTIC DISORDER | 6 0.06 87.31 PULMONARY ARTERIAL HYPERTENSION | 9 0.09 87.40 PULMONARY EMBOLISM | 4 0.04 87.44 PULMONARY FIBROSIS | 2 0.02 87.46 PULMONARY HAEMORRHAGE | 1 0.01 87.47 PULMONARY HYPERTENSION | 4 0.04 87.51 PULMONARY SARCOIDOSIS | 1 0.01 87.52 PULMONARY TUBERCULOSIS | 2 0.02 87.54 PUSTULAR PSORIASIS | 2 0.02 87.56 PYODERMA GANGRENOSUM | 2 0.02 87.58 PYREXIA | 25 0.25 87.83 RASH | 7 0.07 87.90 RASH PRURITIC | 1 0.01 87.91 RASH VESICULAR | 1 0.01 87.92 RAYNAUD'S PHENOMENON | 1 0.01 87.93 RECTAL CANCER | 6 0.06 87.99 RECTAL CANCER RECURRENT | 9 0.09 88.08 REFLUX GASTRITIS | 1 0.01 88.09 REFLUX OESOPHAGITIS | 6 0.06 88.15 REFRACTORY ANAEMIA | 1 0.01 88.16 REGURGITATION | 1 0.01 88.17 REITER'S SYNDROME | 4 0.04 88.21 RELAPSING-REMITTING MULTIPLE SCLEROSIS | 5 0.05 88.26 RENAL CANCER | 8 0.08 88.34 RENAL CANCER METASTATIC | 4 0.04 88.38 RENAL CELL CARCINOMA | 33 0.33 88.71 RENAL CELL CARCINOMA STAGE IV | 15 0.15 88.86 RENAL COLIC | 1 0.01 88.87 RENAL FAILURE | 3 0.03 88.90 RENAL FAILURE CHRONIC | 24 0.24 89.14 RENAL IMPAIRMENT | 1 0.01 89.15 RENAL OSTEODYSTROPHY | 1 0.01 89.16 RENAL TRANSPLANT | 43 0.43 89.59 RESORPTION BONE INCREASED | 1 0.01 89.60 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 1 0.01 89.61 RESPIRATORY TRACT INFECTION | 11 0.11 89.72 RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 89.73 RESTLESS LEGS SYNDROME | 26 0.26 89.99 RETINAL DETACHMENT | 2 0.02 90.01 RETINAL HAEMORRHAGE | 3 0.03 90.04 RETINAL VEIN OCCLUSION | 1 0.01 90.05 RETINAL VEIN THROMBOSIS | 1 0.01 90.06 RHEUMATOID ARTHRITIS | 259 2.59 92.65 RHINITIS | 2 0.02 92.67 RHINITIS ALLERGIC | 7 0.07 92.74 RHINITIS SEASONAL | 1 0.01 92.75 ROUTINE HEALTH MAINTENANCE | 1 0.01 92.76 SALIVARY HYPERSECRETION | 1 0.01 92.77 SARCOIDOSIS | 4 0.04 92.81 SARCOMA UTERUS | 1 0.01 92.82 SCAN | 1 0.01 92.83 SCAN MYOCARDIAL PERFUSION | 1 0.01 92.84 SCHIZOAFFECTIVE DISORDER | 5 0.05 92.89 SCHIZOPHRENIA | 47 0.47 93.36 SCHIZOPHRENIA, DISORGANISED TYPE | 5 0.05 93.41 SCHIZOPHRENIA, PARANOID TYPE | 10 0.10 93.51 SCIATICA | 3 0.03 93.54 SCLERODERMA | 1 0.01 93.55 SCOLIOSIS SURGERY | 3 0.03 93.58 SEASONAL ALLERGY | 11 0.11 93.69 SEBORRHOEA | 1 0.01 93.70 SECONDARY PROGRESSIVE MULTIPLE SCLERO.. | 1 0.01 93.71 SEDATION | 12 0.12 93.83 SEDATIVE THERAPY | 2 0.02 93.85 SELF INJURIOUS BEHAVIOUR | 1 0.01 93.86 SEPSIS | 9 0.09 93.95 SEPTIC SHOCK | 11 0.11 94.06 SERONEGATIVE ARTHRITIS | 3 0.03 94.09 SERUM FERRITIN INCREASED | 1 0.01 94.10 SHWACHMAN-DIAMOND SYNDROME | 12 0.12 94.22 SINUS CONGESTION | 3 0.03 94.25 SINUS DISORDER | 1 0.01 94.26 SINUSITIS | 18 0.18 94.44 SJOGREN'S SYNDROME | 2 0.02 94.46 SKIN DISORDER | 1 0.01 94.47 SKIN EXFOLIATION | 1 0.01 94.48 SKIN LESION | 1 0.01 94.49 SKIN WRINKLING | 2 0.02 94.51 SLE ARTHRITIS | 1 0.01 94.52 SLEEP DISORDER | 30 0.30 94.82 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 2 0.02 94.84 SMALL FOR DATES BABY | 1 0.01 94.85 SMOKING CESSATION THERAPY | 83 0.83 95.68 SOMNOLENCE | 1 0.01 95.69 SPINAL ANAESTHESIA | 3 0.03 95.72 SPINAL COMPRESSION FRACTURE | 2 0.02 95.74 SPINAL CORD COMPRESSION | 1 0.01 95.75 SPINAL CORD NEOPLASM | 2 0.02 95.77 SPINAL FRACTURE | 2 0.02 95.79 SPINAL FUSION SURGERY | 1 0.01 95.80 SPINAL OSTEOARTHRITIS | 1 0.01 95.81 SQUAMOUS CELL CARCINOMA | 4 0.04 95.85 STAPHYLOCOCCAL INFECTION | 5 0.05 95.90 STAPHYLOCOCCAL SEPSIS | 1 0.01 95.91 STAPHYLOCOCCAL SKIN INFECTION | 1 0.01 95.92 STATUS EPILEPTICUS | 5 0.05 95.97 STEM CELL TRANSPLANT | 6 0.06 96.03 STENT PLACEMENT | 9 0.09 96.12 STEROID THERAPY | 1 0.01 96.13 STILL'S DISEASE ADULT ONSET | 3 0.03 96.16 STRESS | 2 0.02 96.18 STRESS URINARY INCONTINENCE | 1 0.01 96.19 STRIDOR | 1 0.01 96.20 SUBCUTANEOUS ABSCESS | 1 0.01 96.21 SUPPLEMENTATION THERAPY | 9 0.09 96.30 SUPRAVENTRICULAR TACHYCARDIA | 1 0.01 96.31 SURGERY | 6 0.06 96.37 SWELLING | 3 0.03 96.40 SYSTEMIC LUPUS ERYTHEMATOSUS | 4 0.04 96.44 T-CELL TYPE ACUTE LEUKAEMIA | 2 0.02 96.46 TACHYARRHYTHMIA | 1 0.01 96.47 TACHYCARDIA | 3 0.03 96.50 TEMPORAL ARTERITIS | 3 0.03 96.53 TENDONITIS | 1 0.01 96.54 TENOSYNOVITIS STENOSANS | 1 0.01 96.55 THINKING ABNORMAL | 2 0.02 96.57 THROAT TIGHTNESS | 1 0.01 96.58 THROMBOCYTOPENIA | 3 0.03 96.61 THROMBOSIS | 5 0.05 96.66 THROMBOSIS PROPHYLAXIS | 28 0.28 96.94 THROMBOTIC THROMBOCYTOPENIC PURPURA | 1 0.01 96.95 THYROID CANCER | 2 0.02 96.97 THYROID DISORDER | 13 0.13 97.10 THYROIDECTOMY | 1 0.01 97.11 TIC | 1 0.01 97.12 TILT TABLE TEST | 1 0.01 97.13 TINEA PEDIS | 1 0.01 97.14 TOBACCO ABUSE | 2 0.02 97.16 TOBACCO USER | 5 0.05 97.21 TONSILLITIS | 3 0.03 97.24 TOOTH ABSCESS | 2 0.02 97.26 TOOTH INFECTION | 1 0.01 97.27 TOURETTE'S DISORDER | 3 0.03 97.30 TRANSIENT ISCHAEMIC ATTACK | 4 0.04 97.34 TRANSITIONAL CELL CARCINOMA | 1 0.01 97.35 TREMOR | 1 0.01 97.36 TRIGEMINAL NEURALGIA | 9 0.09 97.45 TUBERCULIN TEST | 3 0.03 97.48 TUBERCULOSIS | 4 0.04 97.52 TYPE 1 DIABETES MELLITUS | 27 0.27 97.79 TYPE 2 DIABETES MELLITUS | 105 1.05 98.84 TYPE IIA HYPERLIPIDAEMIA | 2 0.02 98.86 TYPHOID FEVER | 1 0.01 98.87 ULCER | 3 0.03 98.90 ULTRASOUND SCAN | 1 0.01 98.91 UPPER RESPIRATORY TRACT INFECTION | 5 0.05 98.96 UPPER RESPIRATORY TRACT INFLAMMATION | 4 0.04 99.00 URINARY INCONTINENCE | 2 0.02 99.02 URINARY TRACT DISORDER | 1 0.01 99.03 URINARY TRACT INFECTION | 23 0.23 99.26 URINE ANALYSIS ABNORMAL | 1 0.01 99.27 UTERINE CANCER | 4 0.04 99.31 UTERINE HAEMORRHAGE | 1 0.01 99.32 UTERINE LEIOMYOMA | 1 0.01 99.33 UVEITIS | 3 0.03 99.36 VAGINAL DYSPLASIA | 1 0.01 99.37 VAGINAL ERYTHEMA | 1 0.01 99.38 VAGINAL HAEMORRHAGE | 1 0.01 99.39 VARICOSE VEIN | 1 0.01 99.40 VASCULAR GRAFT | 1 0.01 99.41 VASCULITIS | 1 0.01 99.42 VASODILATATION | 1 0.01 99.43 VENTRICULAR ARRHYTHMIA | 1 0.01 99.44 VENTRICULAR EXTRASYSTOLES | 1 0.01 99.45 VENTRICULAR FAILURE | 1 0.01 99.46 VENTRICULAR TACHYCARDIA | 1 0.01 99.47 VERTIGO | 1 0.01 99.48 VIRAL INFECTION | 6 0.06 99.54 VISUAL FIELD DEFECT | 1 0.01 99.55 VITAMIN D DEFICIENCY | 1 0.01 99.56 VITAMIN SUPPLEMENTATION | 6 0.06 99.62 VOMITING | 13 0.13 99.75 VON HIPPEL-LINDAU DISEASE | 1 0.01 99.76 VULVOVAGINAL CANDIDIASIS | 2 0.02 99.78 VULVOVAGINAL DRYNESS | 2 0.02 99.80 WALDENSTROM'S MACROGLOBULINAEMIA | 1 0.01 99.81 WEIGHT CONTROL | 3 0.03 99.84 WEIGHT LOSS DIET | 7 0.07 99.91 WHEEZING | 2 0.02 99.93 WHITE BLOOD CELL COUNT DECREASED | 2 0.02 99.95 WHITE BLOOD CELL COUNT INCREASED | 1 0.01 99.96 WITHDRAWAL SYNDROME | 1 0.01 99.97 WOLFF-PARKINSON-WHITE SYNDROME | 1 0.01 99.98 WOUND | 1 0.01 99.99 WOUND INFECTION | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015